Opthea To Present at Sequire Biotechnology Conference
MELBOURNE, Australia , Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin , the Company’s Chief Executive
January 30, 2023
Read More
Displaying 61 - 70 of 146